LecTec Ships First TheraPatch Orders to Kmart and Target
Growing TheraPatch(R) National Retail Distribution Now Includes Eckerd, Kmart,
Safeway, SuperValu, Target, Walgreens and Wal-Mart

MINNETONKA, MN--Sept. 14, 1999--LecTec Corporation (Nasdaq National Market:LECT) today announced that distribution for its new TheraPatch over-the-counter topical drug delivery patches has grown to include the national retailers Kmart and Target, in addition to the previously established retailers Eckerd, Safeway, SuperValu, Walgreens and Wal-Mart.

"We are excited about our ability to establish distribution with these large retailers, considering we entered the health care consumer products market exactly one year ago," commented Rodney A. Young, Chairman, CEO and President. "We believe our ability to gain nation-wide distribution, in a very short period of time, with these and other prominent retail organizations is a testament to the unique and innovative characteristics of our TheraPatch over-the-counter topical drug delivery technology. Retail buyers are electing to sell our TheraPatch products because they recognize the opportunity to provide their customers new and innovative products as well as realize attractive margins associated with TheraPatch products. There is great enthusiasm about our `first in the category', convenient, non-messy, and easy-to-use patch products," Young continued.

"The recent shipment of our TheraPatch products to Target and Kmart, as well as other national retailers: Drug Emporium, Duane Reade, Fred Meyer, Genovese, Longs, Lucky, Marc's, Meijer, Osco, Phar-mor, Sav-on, Snyder, and Winn Dixie increases the number of retail locations where you can purchase TheraPatch from 11,000 to over 17,000. Within the next several months, we anticipate continued expansion of our TheraPatch distribution to include other significant national food, drug and mass retailers," concluded Young.

A pipeline of innovative, new products, patented patch technology, and the company's ability to be fast and flexible are the Company's stated competitive advantages.

LecTec is a health care company that develops, manufactures and markets products based on its advanced skin interface technologies. Primary products include over-the-counter patch products, diagnostic electrodes and conductive hydrogels for electrocardiography and related applications, and a full line of medical tapes.

This press release contains forward-looking statements that may include statements regarding intent, belief or current expectations of the company and its management. These forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that may cause the Company's actual results to differ materially from the results discussed in these statements. Factors that might cause such differences include, but are not limited to, buying patterns of major customers, market acceptance of LecTec's products, competitive products, and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission.

CONTACT: LecTec Corporation, Minnetonka
Rodney A. Young, CEO

or

Timothy R. J. Quinn, General Manager
Consumer Products Division

(612) 933-2291